Question 5614 — human blood and organs

Summary

The Government supports the activities of the French Blood Establishment (EFS) and works to preserve the French ethical model, sovereignty and quality of the transfusion chain. In this context, the attractiveness of professions is supported through upgrades and the modernization of career paths. An increase in the prices of labile blood products of 3.3% in 2021 made it possible to finance a budget of €20 million intended for an increase in salaries transposing the Ségur de la santé. The 2023 social security financing bill also records the allocation of an additional allocation of €15 million, in addition to the allocation of €10 million for Health Insurance, the trajectory of which was established in 2019. This allocation aims to take into account the consequences of inflation. Furthermore, the trajectory of revaluation of plasma prices continues, after an increase of 8.4% on January 1, 2022, a further increase of 9% is planned in 2023. The attractiveness of the EFS professions, essential to ensure the continuity of the activity of supervision of donations, is supported by the development of telemedical assistance in collection, by the evolution of the training of collection professionals, by support in the promotion of donation and the modernization of relations with donors. Finally, the establishment is also financially supported for certain innovation and research activities, particularly in the field of organic production. The Government welcomes the commitment of donor associations and remains very attentive to the management of stocks of labile blood products essential to the hospital care of patients throughout the national territory, and more generally, to the preservation of the French model of transfusion.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.